← Back to the idea

SLC25A45-Based Metabolic Biomarker Panel

A diagnostic blood test measuring SLC25A45 mutation status and methylated amino acid levels to identify a specific metabolic phenotype that may influence response to GLP-1 receptor agonist weight-loss drugs. The panel targets potential bottlenecks in carnitine biosynthesis that could hinder the body's ability to mobilize fat.